This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ruiz-Doblado, S. Articles by De La O Caraballo-Camacho, M. Search for Related Content PubMed PubMed Citation Articles by Ruiz-Doblado, S. Articles by De La O Caraballo-Camacho, M. Social Bookmarking                         What's this?

Pharmacoepidemiological Patterns of Antidepressant Prescribing in Primary Care in Rural Spain (1995-1999)

Consultation-Liaison Psychiatric Unit, Osuna Hospital, Seville, Spain; Unidad de Psiquiatría de Enlace, Hospital de Osuna, Avda. Constitución, 2, 41640 Osuna, Sevilla, Spain. Phone: 00-34-55-077367. Facsimile: 00-34-55-820544. sergioruiz{at}ozu.es

María De La O Caraballo-Camacho

Public Primary Care Pharmacy Department, Osuna Health Area, Seville, Spain

Background: The prescribing of psychoactive drugs is increasing progressively in western countries. The new psychiatric care modalities, in contact with the primary care centres and closer to the population, might be determining this increase in a major way.

Methods: Official data of prescription were collected from the Public Primary Care Department of Pharmacy, to monitor the use of antidepressants during a five year period in a rural health area (140,359 inhabitants). Daily defined dosage (DDD) was used as the measuring unit.

Results and conclusions: The total use of antidepressants increased progressively during the period studied from 10.47 DDD/1000 inhabitants/day in 1995 to 18.50 in 1999 (an increase of 77.08%). The majority of this increase is explained by the greater use of SSRIs for which prescribing multiplied by 2.5. It is significant that the figure for the use of tricyclics has not fallen parallel to the increase of SSRIs. General practitioners might be losing their fear of diagnosing and treating mood disorders. Probably a pool of patients is included who were not receiving the correct treatment a few years ago, but to what level are we going to lower the symptomatic threshold for prescribing antidepressants?

International Journal of Social Psychiatry, Vol. 48, No. 1, 71-77 (2002)
DOI: 10.1177/002076402128783109


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?